Jpmorgan Chase & CO Liquidia Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Liquidia Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 24,640 shares of LQDA stock, worth $271,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,640
Previous 19,591
25.77%
Holding current value
$271,286
Previous $288,000
2.43%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LQDA
# of Institutions
162Shares Held
36MCall Options Held
1.79MPut Options Held
380K-
Patient Square Capital LP Menlo Park, CA7.18MShares$79.1 Million40.01% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$46.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$37.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.4MShares$26.4 Million13.89% of portfolio
-
State Street Corp Boston, MA2.23MShares$24.6 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $709M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...